Kitty
Senior Member (Voting Rights)
Do you have a link to the JCVI info?
I can't remember which document it was now, but there's something on gov.uk (specifically about heath and care workers) that contains very similar wording:

Advice accepted on autumn 2025 COVID-19 vaccination programme
The government has accepted advice from the Joint Committee on Vaccination and Immunisation (JCVI) for the autumn 2025 COVID-19 vaccination programme.
In the current era of high population immunity to COVID-19, additional COVID-19 doses provide very limited, if any, protection against infection and any subsequent onward transmission of infection.
By the same token, it's not a given that vaccination would provide a net benefit to people who're at low risk of infection in the first place.
The vaccine programme is about trying to reduce the risk of severe illness, not stopping people getting infected. But if your exposure to the virus is much lower than normal because you're not socialising unprotected, it follows that your risk of severe illness is also lower than normal.
The risk weighting then starts to shift the other way. Some people do get side effects from Covid vaccines, possibly at a higher rate than has been realised, so is that a bigger risk than developing severe Covid symptoms?
Obviously I don't know, but that's the point I was making.
For people with ME/CFS who're not on immune suppression and don't have any of the conditions known to be associated with severe Covid, it's unclear whether the vaccine would help. The risk is not so much that they might end up with respiratory failure, but that the virus (like any other infection) has the potential to make their ME/CFS worse. If the vaccine could help them avoid infection it'd definitely be worth it, but often it doesn't.